Tags

Type your tag names separated by a space and hit enter

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China.
Front Pharmacol. 2022; 13:1013485.FP

Abstract

Objective: The present study aims to assess the willingness to pay (WTP) for and willingness to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when the pandemic is under adequate control and the majority of the population is vaccinated. This study is also to identify significant factors associated with the WTP. Methods: This was a cross-sectional study on adults with no past or present COVID-19 infection. An online questionnaire was distributed to collect data on vaccination status, quarantine experience, and factors related to health beliefs on vaccination. The WTV was assessed through the vaccination preference. The WTP was examined by payment scale (PS) and iterative bidding game (IBG) administered in random order. Three IBG algorithms with different starting-price were presented randomly. The average WTP of PS and IBG were analyzed as primary outcomes using univariate and multivariate analyses. Multivariate ordered logistic regression was performed to identify significant factors for the WTP. Results: The survey recruited 543 participants with a mean age of 32 years and 57.80% being female. The WTV rate was 86.74%, while 94.66% of participants completed full-schedule or enhanced vaccination. The mean WTP was CNY 149 (±CNY 197) and the median WTP was CNY 80. Regarding significant factors for the WTP, urban residents were 57% more likely (95% CI: 1.11-2.22) to pay for a high-priced vaccine than rural residents. Respondents who completed full-schedule vaccination were 46% more likely (95% CI: 1.03-2.07) to pay for a high-priced vaccine than those who completed enhanced vaccination. Respondents with a low household income of CNY 40k or lower were 62% less likely (95% CI: 0.21-0.66) to pay for a high-priced vaccine than those with a middle household income of CNY 110k-210k. Other significant factors associated with the WTP included the perceived benefit of vaccination and peer environmental pressure in the health belief model. Conclusion: The WTV with the COVID-19 vaccine booster dose was high in China. The WTP was influenced by the place of residence, vaccination status, household income, perceived benefit of vaccination, and environmental peer pressure. Study findings can inform policymakers to better design vaccination programs and financial schemes involving out-of-pocket payments.

Authors+Show Affiliations

Department of Public Administration, Business School, University of Shanghai for Science and Technology, Shanghai, China.Department of Public Administration, Business School, University of Shanghai for Science and Technology, Shanghai, China.Department of Public Administration, Business School, University of Shanghai for Science and Technology, Shanghai, China.Department of Orthopedics, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.School of Public Health, Fudan University, Shanghai, China. Key Lab of Health Technology Assessment, National Health Commission, Fudan University, Shanghai, China.College of Pharmacy, Univesity of Tennessee Health Science Center, Memphis, TN, United States.I.Baby Preconception Care, Shanghai, China.Department of Clinical Pharmacy and Translational Science, Univesity of Tennessee Health Science Center, Memphis, TN, United States.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36204240

Citation

Zhou, Hui Jun, et al. "Willingness to Pay for and Willingness to Vaccinate With the COVID-19 Vaccine Booster Dose in China." Frontiers in Pharmacology, vol. 13, 2022, p. 1013485.
Zhou HJ, Pan L, Shi H, et al. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Front Pharmacol. 2022;13:1013485.
Zhou, H. J., Pan, L., Shi, H., Luo, J. W., Wang, P., Porter, H. K., Bi, Y., & Li, M. (2022). Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Frontiers in Pharmacology, 13, 1013485. https://doi.org/10.3389/fphar.2022.1013485
Zhou HJ, et al. Willingness to Pay for and Willingness to Vaccinate With the COVID-19 Vaccine Booster Dose in China. Front Pharmacol. 2022;13:1013485. PubMed PMID: 36204240.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. AU - Zhou,Hui Jun, AU - Pan,Lei, AU - Shi,Hui, AU - Luo,Ji Wei, AU - Wang,Pei, AU - Porter,Hannah K, AU - Bi,Ye, AU - Li,Minghui, Y1 - 2022/09/20/ PY - 2022/08/07/received PY - 2022/09/09/accepted PY - 2022/10/7/entrez PY - 2022/10/8/pubmed PY - 2022/10/8/medline KW - COVID-19 KW - booster KW - health belief model KW - iterative bidding game KW - vaccine KW - willingness to pay KW - willingness to vaccinate SP - 1013485 EP - 1013485 JF - Frontiers in pharmacology JO - Front Pharmacol VL - 13 N2 - Objective: The present study aims to assess the willingness to pay (WTP) for and willingness to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when the pandemic is under adequate control and the majority of the population is vaccinated. This study is also to identify significant factors associated with the WTP. Methods: This was a cross-sectional study on adults with no past or present COVID-19 infection. An online questionnaire was distributed to collect data on vaccination status, quarantine experience, and factors related to health beliefs on vaccination. The WTV was assessed through the vaccination preference. The WTP was examined by payment scale (PS) and iterative bidding game (IBG) administered in random order. Three IBG algorithms with different starting-price were presented randomly. The average WTP of PS and IBG were analyzed as primary outcomes using univariate and multivariate analyses. Multivariate ordered logistic regression was performed to identify significant factors for the WTP. Results: The survey recruited 543 participants with a mean age of 32 years and 57.80% being female. The WTV rate was 86.74%, while 94.66% of participants completed full-schedule or enhanced vaccination. The mean WTP was CNY 149 (±CNY 197) and the median WTP was CNY 80. Regarding significant factors for the WTP, urban residents were 57% more likely (95% CI: 1.11-2.22) to pay for a high-priced vaccine than rural residents. Respondents who completed full-schedule vaccination were 46% more likely (95% CI: 1.03-2.07) to pay for a high-priced vaccine than those who completed enhanced vaccination. Respondents with a low household income of CNY 40k or lower were 62% less likely (95% CI: 0.21-0.66) to pay for a high-priced vaccine than those with a middle household income of CNY 110k-210k. Other significant factors associated with the WTP included the perceived benefit of vaccination and peer environmental pressure in the health belief model. Conclusion: The WTV with the COVID-19 vaccine booster dose was high in China. The WTP was influenced by the place of residence, vaccination status, household income, perceived benefit of vaccination, and environmental peer pressure. Study findings can inform policymakers to better design vaccination programs and financial schemes involving out-of-pocket payments. SN - 1663-9812 UR - https://www.unboundmedicine.com/medline/citation/36204240/Willingness_to_pay_for_and_willingness_to_vaccinate_with_the_COVID_19_vaccine_booster_dose_in_China_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.